Navigation Links
YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
Date:2/10/2011

3,246,067) $(153,130,276) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Basic and diluted loss per common share $ (0.10) $ (0.06) $ (0.19) $ (0.12) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of common shares outstanding 85,323,592 55,888,710 82,853,129 55,862,879 ------------------------------------------------------------------------- ------------------------------------------------------------------------- YM BIOSCIENCES INC. Interim Consolidated Statements of Cash Flows (Expressed in Canadian dollars, unless otherwise noted) ------------------------------------------------------------------------- Three months ended Six months ended December 31, December 31, 2010 2009 2010 2009 ------------------------------------------------------------------------- (Unaudited) (Unaudited) Cash provided by (used in): Operating activities: Loss for the period $ (8,383,337) $ (3,375,537) $ (16,000,752) $ (6,878,325) Items not involving cash: Amortiza- tion of property and equipment 19,789 17,331 39,147 33,583 Amortiza- tion of intangible assets 1,127,004 265,135 2,254,008 530,271 Unrealized loss (gain) on short- term deposits (4,152) 6,888 (11,123) 9,106 Gain on disposal of property and equipment - - (10,744) - Stock-based compensation 399,475 118,046 999,935 514,690 Change in non-cash operating working capital: Accounts receivable and prepaid expenses (407,406) 87,560 (298,695) 333,595 Accounts payable, accrued liabili- ties and deferred revenue 1,364,785 (722,825) 1,699,050 (727,675) ----------------------------------------------------------------------- (5,883,842) (3,603,402) (11,329,174) (6,184,755) Financing activities: Issuance of common shares on exercise of options 238,809 51,165 253,809 62,589 Issue of common shares on exercise of warrants 850,
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
2. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
3. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
4. Ardea Biosciences Prices Public Offering of Common Stock
5. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students
8. YM BioSciences Closes Public Offering of Common Shares
9. YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING
10. Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
11. Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Research and Markets  has announced ... (Biodegradable Polymer, Food & Beverage, Personal Care & ... report to their offering. Lactic ... asymmetrical carbon atom. The main applications of lactic ... beverage, personal care product, and pharmaceutical industries. ...
(Date:8/27/2014)... , Aug. 27, 2014 Guggenheim Securities, the ... today announced the hiring of veteran equity analyst Charles ... analyst. Mr. Butler will focus on the biotech/biopharma sector. ... a wealth of experience and a broad network of ... Senior Managing Director and Head of Equities at Guggenheim ...
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014" ... Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 ... state of the global isotope ratio mass spectrometer industry. ... the industry including definitions, classifications, applications and industry chain ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 BIOEQUA, an ... through the use of a handheld spray, has made ... United States. , The brand began with an ... researchers were surprised to learn that the application of ... extremely small and delivered directly to skin's basal layer. ...
Breaking Biology Technology:Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2
... current science and experience does not support the safety ... therapies. At a public hearing last week, the Plasma ... and Drug Administration (FDA) to make patient safety its ... evaluation of plasma protein therapies for the biosimilars process. ...
... An Agreement in Principle with NOVA Home Loans ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... study from Thomson Reuters released today shows that the US is ... not kept pace with the increased output from European and Asia-Pacific ... , found that research output from the US has been surpassed ... nearly 40 percent of research papers in the most influential journals(1). ...
Cached Biology Technology:Plasma Protein Therapies Not Suitable for Biosimilars 2Plasma Protein Therapies Not Suitable for Biosimilars 3Plasma Protein Therapies Not Suitable for Biosimilars 4Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 2Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 3Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 4Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 5Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 6Dynamic Ventures Corp. Reaches An Agreement in Principle with NOVA Home Loans 7US Dominance in Scientific Research Significantly Challenged by Increased Competition from Europe and Asia, According to Thomson Reuters Study 2
(Date:8/27/2014)... mysteries of the human genome was unveiled today in ... detailed comparison yet of how the genomes of the ... research, appearing August 28 in in the journal ... three species, genomes is "read out," and how their ... results add billions of entries to a publicly available ...
(Date:8/27/2014)... Many African-Americans may not be getting effective doses of ... Hopkins suggests. The initial dosing studies, completed before the ... generally lack a protein that is key to removing ... people with maximum levels of the protein including ... maraviroc in their bodies compared to those who lack ...
(Date:8/27/2014)... SALT LAKE CITY, Aug. 27, 2014 University of ... in his native Turkey, has won that nation,s highest ... Medal of Science. , Sekercioglu is among five researchers ... Scientific and Technical Research Council of Turkey. Three researchers ... won the Special Award, which is equivalent to ...
Breaking Biology News(10 mins):Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Dosage of HIV drug may be ineffective for half of African-Americans 2University of Utah biologist wins Turkey's top science prize 2
... 1, 2010) The goal of tissue engineering is ... and then transplant them into patients, where they are fully ... of high-throughput imaging systems that allow researchers to directly monitor ... improving the culturing and implantation techniques, as well as the ...
... JOLLA, Calif., April 1, 2010 Though heart disease ... little is understood about its genetic underpinnings. Recently, an ... Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham ... light on the subject. Studying Drosophila (fruit flies), the ...
... 2010 Imagine being able to image life as it ... begins beating. A professor at the University of Houston, ... doing just that. Kirill Larin, assistant professor ... UH, and his colleagues in the Texas Medical Center are ...
Cached Biology News:Tissue engineering, imaging neuronal circuits featured in Cold Spring Harbor Protocols 2Mapping heart disease 2The embryonic heart: Imaging life as it happens 2
... to MLF1 Interacting Protein/PBIP1 (phospho T78) ... applications). Antigen: ... acids 73-83 of Human MLF1 Interacting ... ID: 359815 ...
... space and organize gloves, safety glasses, ... are the perfect benchtop storage bins ... processing and manufacturing. Clear static-dissipative PVC ... they attract. Many other sizes and ...
... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Many other ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Fishes microRNA Microarray ...
Biology Products: